Neurol. praxi 2020; 21(Suppl G) | DOI: 10.36290/neu.2020.121

Neurological complications of SARS-CoV-2 coronavirus infection (COVID-19)

Pavel Otruba1, Jan Bardoň1, Milan Kolář2, Lenka Petroušová3, Milan Raška4, Richard Salzman5, Tomáš Dorňák1, Petr Hluštík1, Pavel Hok1, Lenka Hvizdošová1, Michaela Kaiserová1, Michal Král1, Sandra Kurčová1, Jan Mareš1, Zuzana Mateášiková5, Kateřina Menšíková1, Martin Nevrlý1, Petr Polidar1, Matouš Rous1, Zuzana Rous1, Tereza Svrčinová1, Daniel Šaňák1, Tomáš Veverka1, Miroslav Vaštík1, Eva Čecháková6, Petr Kaňovský1
1 Neurologická klinika, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc
2 Ústav mikrobiologie, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc
3 Klinika infekčního lékařství, Fakultní nemocnice Ostrava
4 Ústav imunologie, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc
5 Klinika otorinolaryngologie a chirurgie hlavy a krku, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc
6 Radiologická klinika Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc

In the setting of the current global pandemic of SARS-CoV-2 coronavirus infection, manifested in a number of cases by the COVID-19 disease, the fact that this disease may cause - both directly and indirectly - a number of novel neurological complications has been clearly observed and described; moreover, it can negatively affect the lives of patients with an already diagnosed neurological disease. Some sequelae have been described in larger groups of patients while others in the form of case reports only; further possible complications are instead derived analogically from other similar conditions. The present article summarizes available and up-to-date knowledge on the neurological issues due to the SARS-CoV-2 infection. The introduction briefly summarizes the general background of the topic: biological and epidemiological characteristics of the novel type of coronavirus and their infectology implications as well as the human immune response to the novel type of coronavirus. A summary follows of the information on possible complications in discrete neurology subspecialities, not only in terms of neurological involvement as a result of COVID-19, but also in terms of the overall effect of the global pandemic on patients with a pre-existing neurological disease. The individual parts present the current knowledge on COVID-19 with respect to demyelinating diseases, cerebrovascular diseases, peripheral neuropathies, extrapyramidal disorders, and inflammatory diseases of the central nervous system. The conclusion section summarizes neurology-related complications, i.e. olfactory and gustatory dysfunctions, and possible neuropsychiatric complications.

Keywords: COVID-19, SARS-CoV-2, pandemic, neurological complications.

Published: December 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Otruba P, Bardoň J, Kolář M, Petroušová L, Raška M, Salzman R, et al.. Neurological complications of SARS-CoV-2 coronavirus infection (COVID-19). Neurol. praxi. 2020;21(Suppl. G - Neurologické komplikace koronavirové infekce SARS-COV-2 (COVID-19)):14. doi: 10.36290/neu.2020.121.
Download citation

References

  1. Abboud H, Abboud FZ, Kharbouch H, Arkha Y, El Abbadi N, El Ouahabi A. COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurg. 2020; 140: 49-53. doi: 10.1016/j.wneu.2020.05.193. Go to original source... Go to PubMed...
  2. Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R. Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis. Mayo Clin Proc. 2020; 95(8): 1621-1631. doi:10.1016/j.mayocp.2020.05.030. Go to original source... Go to PubMed...
  3. Ahmed SF, Quadeer AA, McKay MR. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies. Viruses. 2020; 12(3): 254. Published 2020 Feb 25. doi:10.3390/v12030254. Go to original source... Go to PubMed...
  4. AlKetbi R, AlNuaimi D, AlMulla M, AlTalai N, Samir M, Kumar N, AlBastaki U. Acute myelitis as a neurological complication of Covid-19: A case report and MRI findings. Radiol Case Rep. 2020; 15(9): 1591-1595. Published 2020 Jun 6. doi: 10.1016/j.radcr.2020.06.001. Go to original source... Go to PubMed...
  5. American Academy of Otolaryngology-Head and Neck Surgery. COVID-19 Anosmia Reporting Tool. Published March 25, 2020. Accessed April 22, 2020. Dostupný na https://www.entnet .org/content/reporting-tool-patients-anosmia-related-covid-19.
  6. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020; 26(4): 450-452. doi:10.1038/s41591-020-0820-9. Go to original source... Go to PubMed...
  7. Asmundson GJG, Taylor S. Coronaphobia: Fear and the 2019-nCoV outbreak. J Anxiety Disord. 2020; 70: 102196. doi:10.1016/j.janxdis.2020.102196. Go to original source... Go to PubMed...
  8. Bartoš V, Bauer M, Cahliková J, Chytilová J. COVID-19 Crisis Fuels Hostility against Foreigners, SSRN 2020, dostupné z https://ssrn.com/abstract=3593411or http://dx.doi.org/10.2139/ssrn.3593411. Go to original source...
  9. Becker RC. COVID-19-associated vasculitis and vasculopathy [published online ahead of print, 2020 Jul 22]. J Thromb Thrombolysis. 2020;1-13. doi:10.1007/s11239-020-02230-4 Go to original source... Go to PubMed...
  10. Boika AV. A Post-COVID-19 Parkinsonism in the Future?. Mov Disord. 2020; 35(7): 1094. doi: 10.1002/mds.28117. Go to original source... Go to PubMed...
  11. Bousquet J, Akdis C, Jutel M, Bachert C, Klimek L, Agache I, Ansotegui IJ, Bedbrook A, Bosnic-Anticevich S, Canonica GW, Chivato T, Cruz AA, Czarlewski W, Del Giacco S, Du H, Fonseca JA, Gao Y, Haahtela T, Hoffmann-Sommergruber K, Ivancevich JC, Khaltaev N, Knol EF, Kuna P, Larenas-Linnemann D, Mullol J, Naclerio R, Ohta K, Okamoto Y, O'Mahony L, Onorato GL, Papadopoulos NG, Pfaar O, Samolinski B, Schwarze J, Toppila-Salmi S, Teresa Ventura M, Valiulis A, Yorgancioglu A, Zuberbier T; ARIA-MASK study group. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. [published online ahead of print, 2020 Mar 31]. Allergy. 2020; 10.1111/all.14302. doi:10.1111/all.14302. Go to original source...
  12. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020; 395(10227): 912-920. doi: 10.1016/S0140-6736(20)30460-8. Go to original source... Go to PubMed...
  13. Burrell CJ, Howard CR, Murphy FA (eds). Fenner and White´s medical virology. Coronaviruses. Academic Press, 2016: 437-446. Go to original source...
  14. Calda P, Břešťák M, Fischerová D, Zikán M, Smetanová D, Machala L. Koronavirová infekce a těhotenství (COVID-19). Stanovisko České společnosti pro ultrazvuk v porodnictví a gynekologii ČLS JEP. Actual Gyn. 2020; 12: 17-19.
  15. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5(4): 536-544. doi:10.1038/s41564-020-0695-z. Go to original source... Go to PubMed...
  16. Davoudi-Monfared E, Rahmani H, Khalili H, Hajiabdolbaghi M, Salehi M, Abbasian L, Kazemzadeh H, Yekaninejad MS. Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial. [published online ahead of print, 2020 Jul 13]. Antimicrob Agents Chemother. 2020; AAC.01061-20. doi: 10.1128/AAC.01061-20. Go to original source... Go to PubMed...
  17. Divani AA, Andalib S, Di Napoli M, Lattanzi S, Hussain MS, Biller J, McCullough LD, Azarpazhooh MR, Seletska A, Mayer SA, Torbey M. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights. J Stroke Cerebrovasc Dis. 2020; 29(8): 104941. doi:10.1016/j.jstrokecerebrovasdis.2020.104941. Go to original source...
  18. Djamshidian A, Lees AJ. Can stress trigger Parkinson's disease?. J Neurol Neurosurg Psychiatry. 2014; 85(8): 878-881. doi:10.1136/jnnp-2013-305911. Go to original source... Go to PubMed...
  19. Dressler D, Saberi FA. Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort. J Neural Transm 2020; 127: 1271-1274. Go to original source...
  20. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. [published online ahead of print, 2020 Jul 2]. Lancet Neurol. 2020; 19(9): 767-783. doi:10.1016/S1474-4422(20)30221-0. Go to original source... Go to PubMed...
  21. European Centre for Disease Prevention and Control. Situation updates on COVID-19. [online]. 2020-03-08. Dostupný z WWW: https://www.ecdc.europa.eu/en/covid-19/situation-updates.
  22. Ferda J, Mírka H, Baxa J, Beneš J, Matějovič M, Urgentní výpočetní tomografie při podezření na onemocnění COVID-19. Ces Radiol 2020; 74(1): 7-10.
  23. Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 2020; 58(3): 299-301. doi: 10.4193/Rhin20.114 . Go to original source... Go to PubMed...
  24. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, Yuan Q, Xiao X. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020; 39(6): 1011-1019. doi:10.1007/s10096-020-03874-z. Go to original source... Go to PubMed...
  25. Ghasemiyeh P, Borhani-Haghighi A, Karimzadeh I, Mohammadi-Samani S, Vazin A, Safari A, Qureshi AI. Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review. Ther Clin Risk Manag. 2020; 16: 595-605. Published 2020 Jun 30. doi:10.2147/TCRM.S259152. Go to original source... Go to PubMed...
  26. Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, Rusconi S, Gervasoni C, Ridolfo AL, Rizzardini G, Antinori S, Galli M. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020; 71(15): 889-890. doi:10.1093/cid/ciaa330. Go to original source... Go to PubMed...
  27. Giovannoni G, Hawkes C, Lechner-Scott J, Levy M, Waubant E, Gold J. The COVID-19 pandemic and the use of MS disease-modifying therapies. Mult Scler Relat Disord. 2020; 39: 102073. doi: 10.1016/j.msard.2020.102073. Go to original source... Go to PubMed...
  28. Greenberg N, Docherty M, Gnanapragasam S, Wessely S. Managing mental health challenges faced by healthcare workers during covid-19 pandemic. BMJ. 2020; 368: m1211. Published 2020 Mar 26. doi:10.1136/bmj.m1211. Go to original source... Go to PubMed...
  29. Grifoni A, Sidney J, Zhang Y, Scheuermann RH, Peters B, Sette A. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2. Cell Host Microbe. 2020; 27(4): 671-680.e2. doi:10.1016/j.chom.2020.03.002. Go to original source... Go to PubMed...
  30. Guha A, Plzák J, Chovanec M. Face to Face with COVID-19: Highlights of Challenges Encountered in Various ENT Practices Across the Czech Republic (A National Survey). 2020, preprint, dostupmé online https://www.researchgate.net/publication/342648778_Face_to_Face_with_COVID-19_Highlights_of_Challenges_Encountered_in_Various_ENT_Practices_Across_the_Czech_Republic_A_National_Survey doi:10.21203/rs.3.rs-37945/v1. Go to original source...
  31. Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020; 94(22): 959-969. doi:10.1212/WNL.0000000000009566. Go to original source... Go to PubMed...
  32. Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, Zhang L, Han L, Dang S, Xu Y, Yang QW, Xu SY, Zhu HD, Xu YC, Jin Q, Sharma L, Wang L, Wang J. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis. 2020; 71(15): 778-785. doi: 10.1093/cid/ciaa310. Go to original source... Go to PubMed...
  33. Gursel M, Gursel I. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?. Allergy. 2020; 75(7): 1815-1819. doi:10.1111/all.14345. Go to original source... Go to PubMed...
  34. Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Mañas R, de Aragón-Gómez F, Benito-León J. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601-e605. doi:10.1212/WNL.0000000000009619. Go to original source... Go to PubMed...
  35. Helmich RC, Bloem BR. The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities. J Parkinsons Dis. 2020; 10(2): 351-354. doi:10.3233/JPD-202038. Go to original source... Go to PubMed...
  36. Hemmerle AM, Dickerson JW, Herman JP, Seroogy KB. Stress exacerbates experimental Parkinson's disease. Mol Psychiatry. 2014; 19(6): 638-640. doi:10.1038/mp.2013.108. Go to original source... Go to PubMed...
  37. Hoffman LA, Vilensky JA. Encephalitis lethargica: 100 years after the epidemic. Brain. 2017; 140(8): 2246-2251. doi:10.1093/brain/awx177. Go to original source... Go to PubMed...
  38. Hopkins RO, Weaver LK, Pope D, Orme JF, Bigler ED, Larson-LOHR V. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999; 160(1): 50-56. doi:10.1164/ajrccm.160.1.9708059. Go to original source... Go to PubMed...
  39. Hoyer C, Ebert A, Huttner HB, Puetz V, Kallmünzer B, Barlinn K, Haverkamp C, Harloff A, Brich J, Platten M, Szabo K. Acute Stroke in Times of the COVID-19 Pandemic: A Multicenter Study. Stroke. 2020; 51(7): 2224-2227. doi:10.1161/STROKEAHA.120.030395. Go to original source... Go to PubMed...
  40. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. [published correction appears in Lancet. 2020 Jan 30;:]. Lancet. 2020; 395(10223): 497-506. doi:10.1016/S0140-6736(20)30183-5. Go to original source... Go to PubMed...
  41. Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC, Lei HY. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol. 2005; 75(2): 185-94. doi: 10.1002/jmv.20255. PMID: 15602737; PMCID: PMC7166886. Go to original source... Go to PubMed...
  42. Chaves C, Castellanos T, Abrams M, Vazquez C. The impact of economic recessions on depression and individual and social well-being: the case of Spain (2006-2013). Soc Psychiatry Psychiatr Epidemiol. 2018; 53(9): 977-986. doi:10.1007/s00127-018-1558-2. Go to original source... Go to PubMed...
  43. Jo T, Yasunaga H, Michihata N, Sasabuchi Y, Hasegawa W, Takeshima H, Sakamoto Y, Matsui H, Fushimi K, Nagase T, Yamauchi Y. Influence of Parkinsonism on outcomes of elderly pneumonia patients. Parkinsonism Relat Disord. 2018; 54: 25-29. doi:10.1016/j.parkreldis.2018.03.028. Go to original source... Go to PubMed...
  44. Jones C, Humphris GM, Griffiths RD. Psychological morbidity following critical illness-the rationale for care after intensive care. Clin Intensive Care 1998; 9(5): 199-205. DOI: 10.3109/tcic.9.5.199.205. Go to original source...
  45. Kępińska AP, Iyegbe CO, Vernon AC, Yolken R, Murray RM, Pollak TA. Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk. Front Psychiatry. 2020; 11: 72. Published 2020 Feb 26. doi:10.3389/fpsyt.2020.00072. Go to original source... Go to PubMed...
  46. Kerleroux B, Fabacher T, Bricout N, Moïse M, Testud B, Vingadassalom S, Ifergan H, Janot K, Consoli A, Ben Hassen W, Shotar E, Ognard J, Charbonnier G, L'Allinec V, Guédon A, Bolognini F, Marnat G, Forestier G, Rouchaud A, Pop R, Raynaud N, Zhu F, Cortese J, Chalumeau V, Berge J, Escalard S, Boulouis G; SFNR, the ETIS registry, and the JENI-Research Collaborative. Mechanical Thrombectomy for Acute Ischemic Stroke Amid the COVID-19 Outbreak: Decreased Activity, and Increased Care Delays. Stroke. 2020; 51(7): 2012-2017. doi:10.1161/STROKEAHA.120.030373. Go to original source... Go to PubMed...
  47. Khoo A, McLoughlin B, Cheema S, Weil RS, Lambert C, Manji H, Zandi MS, Morrow JM. Postinfectious brainstem encephalitis associated with SARS-CoV-2. J Neurol Neurosurg Psychiatry. 2020; 91(9): 1013-1014. doi: 10.1136/jnnp-2020-323816. Go to original source... Go to PubMed...
  48. Kim MH, Kim HJ, Chang J. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus. PLoS One. 2019; 14(7): e0220196. Published 2019 Jul 22. doi:10.1371/journal.pone.0220196. Go to original source... Go to PubMed...
  49. Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191: 145-147. doi:10.1016/j.thromres.2020.04.013. Go to original source... Go to PubMed...
  50. Kouřil P, Ferenčuhová S. "Smart" quarantine and "blanket" quarantine: the Czech response to the COVID-19 pandemic, Eurasian Geography and Economics, 2020, dostupné online https://rsa.tandfonline.com/doi/full/10.1080/15387216.2020.1783338 DOI: 10.1080/15387216.2020.1783338. Go to original source...
  51. Kremer S, Lersy F, de Sèze J, Ferré JC, Maamar A, Carsin-Nicol B, Collange O, Bonneville F, Adam G, Martin-Blondel G, Rafiq M, Geeraerts T, Delamarre L, Grand S, Krainik A, Caillard S, Marc Constans J, Metanbou S, Heintz A, Helms J, Schenck M, Lefèbvre N, Boutet C, Fabre X, Forestier G, de Beaurepaire I, Bornet G, Lacalm A, Oesterlé H, Bolognini F, Messie J, Hmeydia G, Benzakoun J, Oppenheim C, Bapst B, Megdiche I, Henri-Feugeas MC, Khalil A, Gaudemer A, Jager L, Nesser P, Talla Mba Y, Hemmert C, Feuerstein P, Sebag N, Carré S, Alleg M, Lecocq C, Schmitt E, Anxionnat R, Zhu F, Comby PO, Ricolfi F, Thouant P, Desal H, Boulouis G, Berge J, Kazémi A, Pyatigorskaya N, Lecler A, Saleme S, Edjlali-Goujon M, Kerleroux B, Zorn PE, Mathieu M, Baloglu S, Ardellier FD, Willaume T, Brisset JC, Boulay C, Mutschler V, Hansmann Y, Mertes PM, Schneider F, Fafi-Kremer S, Ohana M, Meziani F, David JS, Meyer N, Anheim M, Cotton F. Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study. [published online ahead of print, 2020 Jun 16]. Radiology. 2020;202222. doi:10.1148/radiol.2020202222. Go to original source... Go to PubMed...
  52. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, Chekkoury-Idrissi Y, Hans S, Delgado IL, Calvo-Henriquez C, Lavigne P, Falanga C, Barillari MR, Cammaroto G, Khalife M, Leich P, Souchay C, Rossi C, Journe F, Hsieh J, Edjlali M, Carlier R, Ris L, Lovato A, De Filippis C, Coppee F, Fakhry N, Ayad T, Saussez S. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8): 2251-2261. doi: 10.1007/s00405-020-05965-1. Go to original source... Go to PubMed...
  53. Lewnard JA, Lo NC. Scientific and ethical basis for social-distancing interventions against COVID-19. Lancet Infect Dis. 2020; 20(6): 631-633. doi: 10.1016/S1473-3099(20)30190-0. Go to original source... Go to PubMed...
  54. Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, Wang D, Mao L, Jin H, Hu B. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020; svn-2020-000431. doi:10.1136/svn-2020-000431. Go to original source...
  55. Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, Liao P, Qiu JF, Lin Y, Cai XF, Wang DQ, Hu Y, Ren JH, Tang N, Xu YY, Yu LH, Mo Z, Gong F, Zhang XL, Tian WG, Hu L, Zhang XX, Xiang JL, Du HX, Liu HW, Lang CH, Luo XH, Wu SB, Cui XP, Zhou Z, Zhu MM, Wang J, Xue CJ, Li XF, Wang L, Li ZJ, Wang K, Niu CC, Yang QJ, Tang XJ, Zhang Y, Liu XM, Li JJ, Zhang DC, Zhang F, Liu P, Yuan J, Li Q, Hu JL, Chen J, Huang AL. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020; 26(6): 845-848. doi:10.1038/s41591-020-0897-1. Go to original source... Go to PubMed...
  56. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. [published online ahead of print, 2020 Apr 10]. JAMA Neurol. 2020; 77(6): 1-9. doi:10.1001/jamaneurol.2020.1127. Go to original source... Go to PubMed...
  57. Mares J, Hartung HP. Multiple sclerosis and COVID-19 [published online ahead of print, 2020 Jul 17]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020; 10.5507/bp.2020.033. doi:10.5507/bp.2020.033. Go to original source... Go to PubMed...
  58. Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, Lantos J, Schenck EJ, Goyal P, Bruce SS, Kahan J, Lansdale KN, LeMoss NM, Murthy SB, Stieg PE, Fink ME, Iadecola C, Segal AZ, Cusick M, Campion TR Jr, Diaz I, Zhang C, Navi BB. Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. [published online ahead of print, 2020 Jul 2]. JAMA Neurol. 2020; e202730. doi:10.1001/jamaneurol.2020.2730. Go to original source... Go to PubMed...
  59. Ministerstvo zdravotnictví České republiky. Aktuálně o koronaviru. [online]. 2020-03-08. Dostupný z https://koronavirus.mzcr.
  60. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H, Kondo K, Myose N, Nakao A, Takeda M, Haro H, Inoue O, Suzuki-Inoue K, Kubokawa K, Ogihara S, Sasaki T, Kinouchi H, Kojin H, Ito M, Onishi H, Shimizu T, Sasaki Y, Enomoto N, Ishihara H, Furuya S, Yamamoto T, Shimada S. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020; 94: 55-58. doi:10.1016/j.ijid.2020.03.062. Go to original source...
  61. MS Trust. Coronavirus, Covid-19 and Multiple Sclerosis. 2020. Dostupné z https://www.mstrust.org.uk/a-z/coronavirus-covid-19-and-multiple-sclerosis.
  62. Munz M, Wessendorf S, Koretsis G, Tewald F, Baegi R, Krämer S, Geissler M, Reinhard M. Acute transverse myelitis after COVID-19 pneumonia. J Neurol. 2020; 267(8): 2196-2197. doi:10.1007/s00415-020-09934-w. Go to original source... Go to PubMed...
  63. Neurologická sekce ČSL JEP. Odborná doporučení Neuroimunologické sekce ČLS JEP pro pacienty s roztroušenou sklerózou v době epidemie COVID - 19. Aktivní život (blog). 17. březen 2020. http://aktivnizivot.cz/2020/03/17/odborna-doporuceni-neuroimunologicke-sekce-cls-jep-pro-pacienty-s-roztrousenou-sklerozou-v-dobe-epidemie-covid-19/.
  64. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, De Leacy RA, Shigematsu T, Ladner TR, Yaeger KA, Skliut M, Weinberger J, Dangayach NS, Bederson JB, Tuhrim S, Fifi JT. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020; 382(20): e60. doi:10.1056/NEJMc2009787. Go to original source... Go to PubMed...
  65. Ozdemir C, Kucuksezer UC, Tamay ZU. Is BCG vaccination affecting the spread and severity of COVID-19?. Allergy. 2020;75(7):1824-1827. doi:10.1111/all.14344. Go to original source... Go to PubMed...
  66. Paderno A, Mattavelli D, Rampinelli V, Grammatica A, Raffetti E, Tomasoni M, Gualtieri T, Taboni S, Zorzi S, Del Bon F, Lombardi D, Deganello A, Redaelli De Zinis LO, Schreiber A. Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects. [published online ahead of print, 2020 Jun 30]. Otolaryngol Head Neck Surg. 2020;194599820939538. doi:10.1177/0194599820939538 Go to original source... Go to PubMed...
  67. Patel A, Charani E, Ariyanayagam D, Abdulaal A, Denny SJ, Mughal N, Moore LSP. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection. [published online ahead of print, 2020 Jun 2]. Clin Microbiol Infect. 2020;26(9):1236-1241. doi:10.1016/j.cmi.2020.05.026 Go to original source... Go to PubMed...
  68. Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, Jayaseelan DL, Kumar G, Raftopoulos RE, Zambreanu L, Vivekanandam V, Khoo A, Geraldes R, Chinthapalli K, Boyd E, Tuzlali H, Price G, Christofi G, Morrow J, McNamara P, McLoughlin B, Lim ST, Mehta PR, Levee V, Keddie S, Yong W, Trip SA, Foulkes AJM, Hotton G, Miller TD, Everitt AD, Carswell C, Davies NWS, Yoong M, Attwell D, Sreedharan J, Silber E, Schott JM, Chandratheva A, Perry RJ, Simister R, Checkley A, Longley N, Farmer SF, Carletti F, Houlihan C, Thom M, Lunn MP, Spillane J, Howard R, Vincent A, Werring DJ, Hoskote C, Jäger HR, Manji H, Zandi MS; UCL Queen Square National Hospital for Neurology and Neurosurgery COVID-19 Study Group. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. [published online ahead of print, 2020 Jul 8]. Brain. 2020; awaa240. doi:10.1093/brain/awaa240. Go to original source... Go to PubMed...
  69. Pavel A, Murray DK, Stoessl AJ. COVID-19 and selective vulnerability to Parkinson's disease. Lancet Neurol. 2020; 19(9): 719 DOI:https://doi.org/10.1016/S1474-4422(20)30269-6. Go to original source... Go to PubMed...
  70. Peng Y, Mentzer AJ, Liu G, Yao X, Yin Z, Dong D, Dejnirattisai W, Rostron T, Supasa P, Liu C, Lopez-Camacho C, Slon-Campos J, Zhao Y, Stuart D, Paeson G, Grimes J, Antson F, Bayfield OW, Hawkins DE, Ker DS, Turtle L, Subramaniam K, Thomson P, Zhang P, Dold C, Ratcliff J, Simmonds P, de Silva T, Sopp P, Wellington D, Rajapaksa U, Chen YL, Salio M, Napolitani G, Paes W, Borrow P, Kessler B, Fry JW, Schwabe NF, Semple MG, Baillie KJ, Moore S, Openshaw PJ, Ansari A, Dunachie S, Barnes E, Frater J, Kerr G, Goulder P, Lockett T, Levin R, Cornall RJ, Conlon C, Klenerman P, McMichael A, Screaton G, Mongkolsapaya J, Knight JC, Ogg G, Dong T. Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients.. Preprint. bioRxiv. 2020;2020.06.05.134551. Published 2020 Jun 8. doi:10.1101/2020.06.05.134551. Go to original source... Go to PubMed...
  71. Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, Belman AL. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. Neurology. 2016; 87(9 Suppl. 2): S38-S45. doi:10.1212/WNL.0000000000002825. Go to original source... Go to PubMed...
  72. Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020; 38(1): 1-9. doi: 10.12932/AP-200220-0772. Go to original source... Go to PubMed...
  73. Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020; 140(1): 1-6. doi:10.1007/s00401-020-02166-2. Go to original source... Go to PubMed...
  74. Reinhold AK, Rittner HL. Barrier function in the peripheral and central nervous system-a review. Pflugers Arch. 2017;469(1):123-134. doi:10.1007/s00424-016-1920-8 Go to original source... Go to PubMed...
  75. Reyes-Bueno JA, García-Trujillo L, Urbaneja P, Ciano-Petersen NL, Postigo-Pozo MJ, Martínez-Tomás C, Serrano-Castro PJ. Miller-Fisher syndrome after SARS-CoV-2 infection. [published online ahead of print, 2020 Jun 5]. Eur J Neurol. 2020; 10.1111/ene.14383. doi:10.1111/ene.14383. Go to original source... Go to PubMed...
  76. Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020; 7(7): 611-627. doi:10.1016/S2215-0366(20)30203-0. Go to original source... Go to PubMed...
  77. Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J, González E, Redondo-Peñas I, Perona-Moratalla AB, Del Valle-Pérez JA, Gracia-Gil J, Rojas-Bartolomé L, Feria-Vilar I, Monteagudo M, Palao M, Palazón-García E, Alcahut-Rodríguez C, Sopelana-Garay D, Moreno Y, Ahmad J, Segura T. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. [published online ahead of print, 2020 Jun 1]. Neurology. 2020;10.1212/WNL.0000000000009937. doi:10.1212/WNL.0000000000009937. Go to original source... Go to PubMed...
  78. Roth J, Harré EM, Rummel C, Gerstberger R, Hübschle T. Signaling the brain in systemic inflammation: role of sensory circumventricular organs. Front Biosci. 2004; 9: 290-300. Published 2004 Jan 1. doi:10.2741/1241. Go to original source... Go to PubMed...
  79. Rudilosso S, Laredo C, Vera V, Vargas M, Renú A, Llull L, Obach V, Amaro S, Urra X, Torres F, Jiménez-Fàbrega FX, Chamorro Á. Acute Stroke Care Is at Risk in the Era of COVID-19: Experience at a Comprehensive Stroke Center in Barcelona. Stroke. 2020; 51(7): 1991-1995. doi:10.1161/STROKEAHA.120.030329. Go to original source... Go to PubMed...
  80. Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: A case report. J Clin Neurosci. 2020; 76: 233-235. doi:10.1016/j.jocn.2020.04.062. Go to original source... Go to PubMed...
  81. Schenkman M, Moore CG, Kohrt WM, Hall DA, Delitto A, Comella CL, Josbeno DA, Christiansen CL, Berman BD, Kluger BM, Melanson EL, Jain S, Robichaud JA, Poon C, Corcos DM. Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol. 2018; 75(2): 219-226. doi:10.1001/jamaneurol.2017.3517. Go to original source... Go to PubMed...
  82. Siu JY. The SARS-associated stigma of SARS victims in the post-SARS era of Hong Kong. Qual Health Res. 2008; 18(6): 729-738. doi:10.1177/1049732308318372. Go to original source... Go to PubMed...
  83. Solé G, Salort-Campana E, Pereon Y, Stojkovic T, Wahbi K, Cintas P, Adams D, Laforet P, Tiffreau V, Desguerre I, Pisella LI, Molon A, Attarian S; FILNEMUS COVID-19 study group. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network. Rev Neurol (Paris). 2020; 176(6): 507-515. doi:10.1016/j.neurol.2020.04.004. Go to original source... Go to PubMed...
  84. Sotoca J, Rodríguez-Álvarez Y. COVID-19-associated acute necrotizing myelitis. Neurol Neuroimmunol Neuroinflamm. 2020; 7(5): e803. Published 2020 Jun 10. doi:10.1212/NXI.0000000000000803. Go to original source... Go to PubMed...
  85. SZÚ ČR. Onemocnění novým koronavirem SARS-CoV-2 (dříve 2019-nCoV), pojmenováno jako "COVID-19" (coronavirus disease 2019) [online]. 2020-01-07. Dostupné z http://www.szu.cz/tema/prevence/onemocneni-novym-koronavirem-2019-ncov.
  86. Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2020; 163(1): 3-11. doi:10.1177/0194599820926473. Go to original source... Go to PubMed...
  87. Trojánek M, Grebenyuk M, Herrmannová K, Nečas T, Gregorová J, Kucbel M, Šín R, Roháčová H, Stejskal F. Nový koronavirus (SARS-CoV-2) a onemocnění COVID-19 Čas. Lék. čes. 2020; 159: 55-66.
  88. Tsai ST, Lu MK, San S, Tsai CH. The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review. Front Neurol. 2020; 11: 498. Published 2020 May 19. doi:10.3389/fneur.2020.00498. Go to original source... Go to PubMed...
  89. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020; 382(16): 1564-1567. doi:10.1056/NEJMc2004973. Go to original source... Go to PubMed...
  90. Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, Sultan M, Easton A, Breen G, Zandi M, Coles JP, Manji H, Al-Shahi Salman R, Menon DK, Nicholson TR, Benjamin LA, Carson A, Smith C, Turner MR, Solomon T, Kneen R, Pett SL, Galea I, Thomas RH, Michael BD; CoroNerve Study Group. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. [published online ahead of print, 2020 Jun 25] [published correction appears in Lancet Psychiatry. 2020 Jul 14;:]. Lancet Psychiatry. 2020; S2215-0366(20)30287-X. doi:10.1016/S2215-0366(20)30287-X. Go to original source... Go to PubMed...
  91. von Weyhern CH, Kaufmann I, Neff F, Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet. 2020; 395(10241): e109. doi:10.1016/S0140-6736(20)31282-4. Go to original source... Go to PubMed...
  92. Wang F, Nie J, Wang H, Zhao Q, Xiong Y, Deng L, Song S, Ma Z, Mo P, Zhang Y. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis. 2020; 221(11): 1762-1769. doi:10.1093/infdis/jiaa150. Go to original source... Go to PubMed...
  93. Widimský P. Fakta a úvahy o pandemii COVID-19. Cor Vasa 2020; 62(Suppl. 1): 11-14 DOI: 10.33678/cor.2020.044. Go to original source...
  94. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review [published online ahead of print, 2020 Jul 10]. JAMA. 2020; 10.1001/jama.2020.12839. doi:10.1001/jama.2020.12839. Go to original source... Go to PubMed...
  95. Xiang YT, Yang Y, Li W, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020; 7(3): 228-229. doi:10.1016/S2215-0366(20)30046-8. Go to original source... Go to PubMed...
  96. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. [published correction appears in Lancet Respir Med. 2020 Feb 25;:]. Lancet Respir Med. 2020; 8(4): 420-422. doi: 10.1016/S2213-2600(20)30076-X. Go to original source... Go to PubMed...
  97. Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, Henninger N, Trivedi T, Lillemoe K, Alam S, Sanger M, Kim S, Scher E, Dehkharghani S, Wachs M, Tanweer O, Volpicelli F, Bosworth B, Lord A, Frontera J. SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020; 51(7): 2002-2011. doi:10.1161/STROKEAHA.120.030335. Go to original source... Go to PubMed...
  98. Ye ZW, Yuan S, Yuen KS, Fung SY, Chan CP, Jin DY. Zoonotic origins of human coronaviruses. Int J Biol Sci. 2020;16(10):1686-1697. Published 2020 Mar 15. doi: 10.7150/ijbs.45472. Go to original source... Go to PubMed...
  99. Zach H, Dirkx MF, Pasman JW, Bloem BR, Helmich RC. Cognitive Stress Reduces the Effect of Levodopa on Parkinson's Resting Tremor. CNS Neurosci Ther. 2017; 23(3): 209-215. doi:10.1111/cns.12670. Go to original source... Go to PubMed...
  100. Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, Wang YY, Xiao GF, Yan B, Shi ZL, Zhou P. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386-389. Published 2020 Feb 17. doi:10.1080/22221751.2020.1729071. Go to original source... Go to PubMed...
  101. Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, Xu Y, Tian Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020; 17(5): 533-535. doi:10.1038/s41423-020-0402-2. Go to original source... Go to PubMed...
  102. Ziaja M. Septic encephalopathy. Curr Neurol Neurosci Rep. 2013; 13(10): 383. doi:10.1007/s11910-013-0383-y. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.